Thiopurine treatment in inflammatory bowel disease.
Gardiner
Sharon J
SJ
Begg
Evan J
EJ
Sau
Ashis
A
Marinaki
Anthony
A
Gearry
Richard B
RB
Barclay
Murray L
ML
D000328:Adult; D000963:Antimetabolites / Q000493:pharmacokinetics / Q000627:therapeutic use; D001942:Breast Feeding; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000378:metabolism; D015122:Mercaptopurine / Q000031:analogs & derivatives / Q000032:analysis / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008895:Milk, Human / Q000737:chemistry
D000963:Antimetabolites; C010240:6-methylthiopurine; D015122:Mercaptopurine
Nephron. 1984;37(1):68
6371564
BJOG. 2007 Apr;114(4):498-501
17261122
Br J Clin Pharmacol. 2006 Oct;62(4):453-6
16995866
Obstet Gynecol. 2001 May;97(5 Pt 2):816-8
11336764
Transplant Proc. 1982 Sep;14(3):605-9
6817481
Transplantation. 1998 Jan 27;65(2):253-5
9458024
Clin Pharmacokinet. 2007;46(3):187-208
17328579
Ann Pharmacother. 2007 Apr;41(4):719-20; author reply 720
17389671
Ann Pharmacother. 2006 Dec;40(12):2269-72
17132809